ColgatePalmolive (CL)
(Delayed Data from NYSE)
$96.49 USD
-0.11 (-0.11%)
Updated Jul 25, 2024 04:00 PM ET
Pre-Market: $97.70 +1.21 (1.25%) 8:20 AM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$96.49 USD
-0.11 (-0.11%)
Updated Jul 25, 2024 04:00 PM ET
Pre-Market: $97.70 +1.21 (1.25%) 8:20 AM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Zacks News
Things You Need to Know Before Colgate's (CL) Q3 Earnings
by Zacks Equity Research
Colgate (CL) is progressing well with its Global Growth and Efficiency Program. However, it witnesses strained margins due to higher raw material and packaging costs.
Colgate-Palmolive (CL) Q3 Earnings Preview: What to Look Out For
by Zacks Equity Research
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Soap & Cleaning Materials Stock Outlook: Near-Term Picture Drab
by Zacks Equity Research
Intense competition as well as increased raw material, transportation and packaging costs are impacting Soap and Cleaning Materials industry, resulting in bleak near-term prospects.
New Strong Sell Stocks for August 1st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Market News For Jul 30, 2018
by Zacks Equity Research
Companies in the news are: CL, SBUX, SAM and EXPE
Colgate's (CL) Q2 Earnings In Line With Estimates, Sales Lag
by Zacks Equity Research
Colgate (CL) delivers first-quarter 2018 earnings in line with the Zacks Consensus Estimate but its sales lag. However, both the top and bottom line improves year over year.
Colgate (CL) Q2 Earnings In Line, Sales Miss, Stock Down
by Zacks Equity Research
Colgate (CL) came out with second-quarter 2018 results, wherein it recorded adjusted earnings of 77 cents per share, which came in line with the Zacks Consensus Estimate.
Will Robust Strategies Fuel Colgate's (CL) Q2 Earnings?
by Zacks Equity Research
Colgate (CL) is encouraged with its savings program along with brand building and productivity maximization initiatives. These, in turn, are likely to drive second-quarter 2018 results.
Trade War Tensions Re-escalate
by Zacks Equity Research
Trade War Tensions Re-escalate
Trade War Rhetoric Heats Up
by Mark Vickery
We "celebrate" Independence Day week, not to mention the first trading day of the second half of the calendar year, re-stoking the fires of a global trade war.
Can Colgate's (CL) Growth Strategies Help Regain Momentum?
by Zacks Equity Research
Colgate's (CL) long-term strategies and earnings trend reflect fundamental strength, positioning it for growth. However, soft-margin trend remains a deterrent.
Implied Volatility Surging for Colgate-Palmolive (CL) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Colgate-Palmolive (CL) stock based on the movements in the options market lately.
Colgate-Palmolive (CL) Down 6.2% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Buyouts & More to Fuel Church & Dwight (CHD) in Q1 Earnings
by Zacks Equity Research
Church & Dwight (CHD) is set to gain from its robust international presence, organic sales trend and focus on buyouts. However, the company remains troubled by commodity and transportation costs.
Colgate (CL) Q1 Earnings Top, Sales Lag Estimates, Stock Down
by Zacks Equity Research
Colgate (CL) came out with first-quarter 2018 results, wherein adjusted earnings of 74 cents per share outpaced the Zacks Consensus Estimate of 73 cents.
Will Clorox (CLX) Retain Positive Earnings Trend in Q3?
by Zacks Equity Research
Clorox's (CLX) weak margin in the last reported quarter is expected to continue in the fiscal third quarter. However, the company's approach toward brand management and Go Lean strategy are impressive.
What's in the Offing for Archer Daniels' (ADM) Q1 Earnings?
by Zacks Equity Research
Archer Daniels (ADM) remains optimistic about delivering growth via cost-savings efforts, innovations and global strength. However, the company has a dismal sales history for more than three years.
Why Colgate-Palmolive (CL) Might Surprise This Earnings Season
by Zacks Equity Research
Colgate-Palmolive (CL) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Why Is Colgate-Palmolive (CL) Down 9.1% Since its Last Earnings Report?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Lockheed Martin, Mastercard, Colgate, Electronic Arts and McKesson
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Lockheed Martin, Mastercard, Colgate, Electronic Arts and McKesson
Will New Products Lift Procter & Gamble's (PG) Q2 Sales?
by Zacks Equity Research
Soft consumer-spending environment and higher competition in developed markets might hurt Procter & Gamble's (PG) Q2 sales. However, new product launches are likely to offset the negatives.
5 Reasons Why Clorox (CLX) is a Must Add Stock Right Now
by Zacks Equity Research
The Clorox Inc. (CLX) stock has been moving up the charts, thanks to the smooth execution of its 2020 strategy. By its actions, the company is poised to boost growth for its categories as well as overall market share.
Colgate (CL) Q3 Earnings in Line, Sales Beat, Stock Down
by Zacks Equity Research
Colgate (CL) came out with third-quarter 2017 adjusted earnings of 73 cents per share, which came in line with Zacks Consensus Estimate.
Will V.F. Corp (VFC) Strategies Facilitate Q3 Earnings Beat?
by Zacks Equity Research
We expect the designer, manufacturer and marketer of branded apparel and related products, V. F. Corporation (VFC) to beat expectations when it reports third-quarter 2017 results on Oct 23.
Will Colgate's Strategic Initiatives Help Counter Sales Woes?
by Zacks Equity Research
Colgate-Palmolive (CL) remains committed to its savings programs with a disciplined capital strategy. However, the company has a dismal sales trend.